602.70
-1.37%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Accent Microcell
Its shares trade on NSE under the ticker ACCENTMIC.NS. It has been listed since 15 December 2023. In the fiscal year to 31 March 2025, it reported revenue of ₹5.29bn and net income of ₹661.3m. At that date it held total assets of ₹2.28bn and shareholders' equity of ₹1.95bn.
Accent Microcell Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-12-15. Accent Microcell Limited is engaged in developing, processing, refining, producing, manufacturing, or buying, importing, stocking, and marketing, selling, exporting, and generally dealing in all kinds of drugs and medicines. Its drugs and medicines include bulk drugs, pharmaceutical formulations in all forms, feed supplements and dietary food supplements and food preparations in allopathic, ayurvedic, umami, homeopathic or other branches of healthcare and treatment of human beings and veterinary applications, antibiotics, herbal, bacteriological and biological products, insecticides, pesticides, fungicides, disinfectants and vermin fugs and raw materials, ingredients, intermediates, semi-finished or finished preparations, compounds, pharmaceutical chemical and microcrystalline cellulose powder, alpha cellulose powder and all kinds of products and by-products. The company has more than 200 plus products in the basket with its presence in different therapeutic segments.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 15 Dec 2023
- Website
- accentmicrocell.com ↗
Leadership
Pay as last reported
- Mr. Ghanshyam PatelChief Financial Officer, Managing Director (Promoter), since 2012₹6.1m
- Mr. Nitin PatelWhole-Time Director (Promoter), since 2012₹6.1m
- Mr. Vasant PatelWhole-Time Director (Promoter), since 2012₹6.1m
- Mr. Vinodbhai PatelWhole-Time Director (Promoter), since 2023₹6.1m
- Ms. Braham ChhabraCompany Secretary
- Mr. Chintan BhattIndependent Director
- Mr. Rajatkumar PatelIndependent Director
- Ms. Shreyaben ShahIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Accent Microcell Ltd has over 200 products in pharmaceuticals including bulk drugs and formulations.
- The company operates in multiple therapeutic segments with diverse healthcare product offerings.
- Accent Microcell Limited develops and markets drugs across allopathic, ayurvedic, and homeopathic branches.
Weaknesses
- The company's IPO listing date is December 15, 2023, which is recent.
- Accent Microcell Ltd is headquartered in Ahmedabad, Gujarat, a regional location.
- The company has limited market presence outside Gujarat and India.
Opportunities
- The Indian pharmaceutical market offers growth potential for companies like Accent Microcell Ltd.
- Expanding into veterinary applications could leverage existing product lines.
- Increasing demand for ayurvedic and herbal products presents new market opportunities.
Threats
- Competition from established pharmaceutical firms in India is intense.
- Regulatory changes in the Indian healthcare sector could impact operations.
- Global supply chain disruptions may affect raw material availability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.